External Advisory Council
Barbara Alving, M.D., MACP
Consultant in Clinical and Translational Science
Director of National Center for Research Resources (2007-11)
Barbara Alving, M.D., who retired from her position as the Director of the National Center for Research Resources (NCRR) at the National Institutes of Health (NIH) in Bethesda, Maryland in September 2011, is an international consultant and a Professor of Medicine at the Uniformed Services University of the Health Sciences in Bethesda. Dr. Alving received her M.D. cum laude from the Georgetown University School of Medicine in Washington, D.C., completed a residency in internal medicine and a research fellowship in hematology at the Johns Hopkins University Hospital in Baltimore, MD, and then became a research investigator at the Food and Drug Administration (FDA) in the Division of Blood and Blood Products on the NIH campus. She continued her research in thrombosis and hemostasis at the Walter Reed Army Institute of Research from 1980-1996, leaving the military at the rank of Colonel. She received the Legion of Merit from the U.S. Army for her work on hemostatic agents for soldiers on the battlefield. Dr. Alving then served as the Director of the Medical Oncology/Hematology Section at the Washington Hospital Center in Washington, D.C. In 1999, she joined the National Heart, Lung, and Blood Institute at NIH as a Division Director, followed by Institute Deputy Director and then Acting Institute Director before moving to NCRR in 2005.
As the Acting Director and then Director of NCRR from 2005-2011, Dr. Alving oversaw an annual investment of more than one billion dollars in academic research institutions for development of new technologies for basic and clinical research, training for researchers in the biomedical sciences, and initiation of programs to provide health and biomedical education for students and the larger public. During this time, the NCRR also established a new initiative in 60 academic health centers known as the Clinical and Translational Science Awards, to increase the efficient translation of discoveries in the laboratory into new treatments and preventive strategies for patients. The institutions are also training investigators to work as interdisciplinary teams.
Dr. Alving is a Master in the American College of Physicians and has served as a member of the subcommittee on Hematology of the American Board of Internal Medicine, as well as the FDA Blood Products Advisory Committee and the Institute of Medicine Drug Forum. She is a co-inventor on two patents, has edited three books, and has published more than 100 papers in the area of thrombosis and hemostasis.
Her current interests include translating biomedical research into treatments and prevention strategies for improving health, both nationally and internationally, in a cost-effective, efficient manner and in developing a team-based interdisciplinary biomedical research work force.
Honors and Credentials
- Recipient of the 2002 American Society of Hematology Award for outstanding service
- Election to Executive Board of American Society of Hematology, 1999 (position terminated with appointment to NHLBI)
- American College of Physicians Mastership conferred 1999
- Laureate Award from the Army Chapter of the American College of Physicians, 1998
- Legion of Merit (1997)-the highest non-combat medal awarded. Received for work in coagulation and hemostasis as applied to the battlefield and to patient care at Walter Reed Army Hospital
- Award of the "A" Proficiency Designator (1991) – the highest award of the Army Medical Department for achievements in clinical and academic medicine
- Meritorious Service Medal (1991) for achievement as research investigator and member of the Walter Reed Army Institute of Research Director's Peer Review Steering Committee
L. Celeste Bottorff
Vice President of Coca-Cola North America
Celeste Bottorff is responsible for building the strategic corporate reputation framework for Coca-Cola North America. In this capacity, Celeste's work is instrumental in designing and communicating the Company's vision for how it delivers on its promise to consumers all across the country that Coca-Cola can be counted to make a positive difference in their lives.
Celeste began her marketing career as a marketing and technology Strategist at McKinsey & Co. in 1983 after earning her Master's degree from the University of Virginia's Darden School of Business. She distinguished herself there by helping clients hone in on strategic imperatives and building game-changing business plans that resulted in successful achievement of business goals.
In addition to her Coca-Cola experience, Celeste served as Senior Vice President of AHL Services where she developed strategies resulting in the transformation of the company to a profitable $970 million public company. As Marketing Director at the Atlanta Journal Constitution, Celeste led marketing initiatives that won the paper "Marketer of the Year" honors from the Newspaper Association of America. Prior to joining the Journal-Constitution, Celeste was the Director of Global Planning for Holiday Inn Worldwide/Intercontinental Hotels. In this role, she developed growth strategies for North America, Asia, Latin America and Europe.
Celeste did not start out as a marketer. A graduate of Purdue University, Celeste earned her B.S in Physics and spent a few years working in operations at the Fermi National Accelerator Laboratory and at General Electric. This depth of knowledge and appreciation for science, coupled with her intuitive sense for what moves consumers to choose one brand over another, makes Celeste uniquely qualified to lead Coca-Cola North America's corporate reputation initiatives.
She is a member of the Board of Advisors for HireDynamics LLC, one of the country's fastest-growing private firms. She also sits on the Purdue University College of Science Dean's Advisory Board and is a member of the Board of Directors of the Cystic Fibrosis Reaching Out Foundation. Celeste served on the Board of Directors at Caraustar Industries for over six years.
Celeste was born in Louisville, Kentucky. She currently resides in Decatur, Georgia.
Honors and Credentials
- 2010 Purdue University's College of Science Distinguished Alumni Award
- 2010 Lifetime Achievement Award from the Cystic Fibrosis Foundation of Georgia
- 2008 Lettie Pate Whitehead Evans Award from the Board of Directors
- 2007 Atlanta Woman magazine's Atlanta Power Women
Rita R. Colwell, Ph.D., D. Sc.(Hon.)
Distinguished University Professor at the University of Maryland at College Park and at Johns Hopkins University Bloomberg School of Public Health
Director of the National Science Foundation (1998-2004)
Dr. Rita Colwell is Distinguished University Professor both at the University of Maryland at College Park and at Johns Hopkins University Bloomberg School of Public Health, Senior Advisor and Chairman Emeritus, Canon US Life Sciences, Inc., and President and Chairman of CosmosID, Inc. Her interests are focused on global infectious diseases, water, and health, and she is currently developing an international network to address emerging infectious diseases and water issues, including safe drinking water for both the developed and developing world.
Dr. Colwell served as the 11th Director of the National Science Foundation, 1998-2004. In her capacity as NSF Director, she served as Co-chair of the Committee on Science of the National Science and Technology Council. One of her major interests include K-12 science and mathematics education, graduate science and engineering education and the increased participation of women and minorities in science and engineering.
Dr. Colwell has held many advisory positions in the U.S. Government, nonprofit science policy organizations, and private foundations, as well as in the international scientific research community. She is a nationally-respected scientist and educator, and has authored or co-authored 17 books and more than 800 scientific publications. She produced the award-winning film, Invisible Seas, and has served on editorial boards of numerous scientific journals.
Before going to NSF, Dr. Colwell was President of the University of Maryland Biotechnology Institute and Professor of Microbiology and Biotechnology at the University Maryland. She was also a member of the National Science Board from 1984 to 1990.
Dr. Colwell has previously served as Chairman of the Board of Governors of the American Academy of Microbiology and also as President of the American Association for the Advancement of Science, the Washington Academy of Sciences, the American Society for Microbiology, the Sigma Xi National Science Honorary Society, and the International Union of Microbiological Societies. Dr. Colwell is a member of the National Academy of Sciences, the Royal Swedish Academy of Sciences, Stockholm, the Royal Society of Canada, and the American Academy of Arts and Sciences, and the American Philosophical Society. She is Immediate Past-President of the American Institute of Biological Sciences (AIBS).
Dr. Colwell has also been awarded 55 honorary degrees from institutions of higher education, including her Alma Mater, Purdue University and is the recipient of the Order of the Rising Sun, Gold and Silver Star, bestowed by the Emperor of Japan, the 2006 National Medal of Science awarded by the President of the United States, and the 2010 Stockholm Water Prize awarded by the King of Sweden. Dr. Colwell is an honorary member of the microbiological societies of the UK, Australia, France, Israel, Bangladesh, Czechoslovakia, Royal Irish Academy, and the U.S. and has held several honorary professorships, including the University of Queensland, Australia. A geological site in Antarctica, Colwell Massif, has been named in recognition of her work in the polar regions.
Born in Beverly, Massachusetts, Dr. Colwell holds a B.S. in Bacteriology and an M.S. in Genetics, from Purdue University, and a Ph.D. in Oceanography from the University of Washington.Honors and Credentials
- 2011 U.S. Civilian Research and Development Foundation Global George Brown Award for International Scientific Cooperation
- 2010 Honorary Member, Royal Irish Academy
- 2010 Stockholm Water Prize
- 2009 Honorary Member, Society for General Microbiology
- 2006 National Medal of Science
- 2007 The David B. Stone Medal, New England Aquarium
- 2007-2008 President-Elect, American Institute of Biological Sciences
- 2005 Honorary Member, World Innovation Foundation
- 2005 Induction, National Women's Hall of Fame
- 2004 Central Intelligence Agency Civilian Recognition Award
- 2004 American Institute of Biological Sciences Outstanding Service Award
- 2003 Elected Member, Royal Swedish Academy of Sciences
- 2002 Fellow, American Academy of Arts and Sciences
- American Association of University Women (AAUW) 2001 Achievement Award
- 2000 Member, National Academy of Sciences
Jennifer Kerr, MS, CCRA, RAC
Cook Research Incorporated
Jennifer L. Kerr is the President of Cook Research Incorporated (a Cook Group Company), in the Purdue Research Park, West Lafayette, Indiana. Jennifer’s role encompasses executive oversight of product development, testing, clinical studies, medical/scientific writing, and regulatory submissions for devices, pharmaceuticals and cell-based therapies. Jennifer holds a bachelor’s degree in Engineering with an emphasis in Biomedical Engineering and a Master’s degree in Physiology from Purdue University. She is dually certified as a Clinical Research Associate (CCRA) from the Association of Clinical Research Professionals (ACRP), and the Regulatory Affairs Professionals Society (RAPS). Beginning in 2010, Jennifer has taught Clinical Design strategies to graduate level biomedical engineering students at Purdue University. In addition, she drove the initiative to host the United States FDA medical device reviewers for multiple workshops on the Management of Clinical Studies (from the physician, patient, site, and sponsor perspective). Jennifer is the Co-Chair of AAMI/BE/WG 04, Clinical Investigations representing the U.S. industry. She is the Global Functional Leader for Clinical Affairs for the Cook organization, and collaborates with global leaders, Regulatory Authorities, and experts on Good Clinical Practice (GCP) in revising the international standard ISO 14155 (Clinical standard for conducting medical device studies). Jennifer has worked with the FDA, Japan MHLW, Japan PMDA and Industry representatives as an active participant in the Harmonization by Doing (HBD) initiative through Working Group 4 to address the best practices for conducting global clinical research.
William R. Killian C.L.P.
Divisional Vice President, Corporate Licensing and Acquisitions
Bill Killian is responsible for licensing and acquisitions for the Nutrition Division of Abbott, a global, broad-based health care company devoted to discovering new medicines, technologies and ways to manage health.
As part of the Corporate Licensing and Acquisitions group, Bill leads a team that works with Abbott R&D and Commercial organizations to identify products, technologies and markets which provide unique science-based nutritional products for patients and consumers of all ages throughout the world so they can live healthier lives.
Bill began his career as a manufacturing engineer in Abbott's Pharmaceutical Division after graduating from Purdue with a B.S. in Chemical Engineering. He subsequently moved into various roles of increasing responsibility managing product and market development for the Diagnostic Division of Abbott.
He then moved into marketing and new business development roles where he identified and evaluated various businesses and technologies for potential development. Responsibilities also included negotiating and executing research and commercial collaborations as well as in-licensing and out-licensing agreements. During the past 10 years, Bill has executed over 50 agreements in the areas of molecular diagnostics, immunology, clinical chemistry, and nutrition.
For the past 5 years, Bill has worked exclusively in the nutrition field on collaborations, licensing and acquisition of technologies or businesses which improve the lives of customers through science-based nutrition. Given the unique needs of emerging markets such as China, Southeast Asia and Latin America, Bill's team has been particularly focused on working with Commercial and R&D teams to identify and develop technologies and products that can serve this growing population.
Bill was born in Baton Rouge, Louisiana and currently resides with his wife, also a Purdue graduate, in Wilmette, Illinois, a suburb of Chicago.
Honors and Credentials
- Certified Licensing Professional (CLP) designation by the Licensing Executives Society
- Lifetime Achievement Award from Abbott's Professional Development Programs
- Various Abbott President's Awards for Innovation and Leadership
- Abbott Corporate Licensing and Acquisitions team has been recognized as the "Most Admired Corporate Dealmakers" in The Deal Magazine survey for the past four years (2008, 2009, 2010 and 2011)
JoAnn A. Suzich, Ph.D.
Vice President, Research, Infections Disease
JoAnn Suzich is a leading scientist and researcher in infectious disease and played a critical role in the advancement and treatment of health issues affecting women and children.
Suzich is vice president for research and development at MedImmune, where she is responsible for overseeing the company's research in the development of antibodies and antibody-like molecules for the prevention and treatment of infectious disease. In addition, she recently assumed responsibility for MedImmune's research on novel vaccines.
Since joining MedImmune in 1988 as a scientist, she has held several positions of increasing responsibility, most recently as senior director, infectious disease research. She has been involved in many key development programs, including Synagis® (palivizumab) which is the only monoclonal antibody approved by the U.S. Food and Drug Administration to help prevent an infectious disease, and the virus-like particle technology that is the basis of the human papillomavirus (HPV) vaccines used to prevent cervical cancer. HPV is thought to be responsible for 70 percent of the instances of cervical cancer.
Suzich's leadership has helped build MedImmune - where she is known as "employee number 13" - from a fledgling company with four employees, founded by fellow Purdue alumnus Wayne Hockmeyer, to an international biotechnology company with more than 3,000 employees worldwide. She has worked closely with all aspects of the company, including discovery research, biopharmaceutical development, clinical research, translational sciences, regulatory affairs, business development, and medical affairs.
Before joining MedImmune, Suzich was a scientist at Molecular Genetics Inc. from 1986-1988. Suzich is the inventor of multiple patents and has authored more than 30 publications. She is the recipient of the Wallace H. Steinberg Award for Innovation.
She holds a bachelor's degree in biology from Susquehanna University, where she graduated magna cum laude. She received her doctorate in biochemistry from Purdue in 1983. She completed a post-doctoral fellowship at the University of Minnesota in 1986. Suzich received an honorary doctorate of agriculture from Purdue in 2011.
Honors and Credentials
- Wallace H. Steinberg Award for Innovation
Elaine Wedral, Ph.D.
Board of Directors of three Food/Chemical Companies
Past President of International Life Sciences Institute
Dr. Elaine Wedral is on the Board of Directors ofthree majorfood/chemical specialty companies andthe Editorial Boardof Food Processing magazine. Dr. Wedral was President of International Life Sciences Institute-NAandwaspresident of Nestle's Food & NutritionR&D center in New Milford, CT while heading R&D strategy and technical development activities for Nestle's International Foodservice business. She spent 34 years with Nestle, in various technical positions including President of ofall U.S. R&D laboratory facilities 1988-2007 and was a member of Nestlé's global R&D management committee.
She began her career at Campbell Soup working in research and development before becoming vice president of development and research for Nestle's Western Hemisphere Research Laboratory. Dr. Wedral also was responsible for the construction of a new world class Pet Food & Nutrition facility as well as a state-of-the-art laboratory for coffee, liquid beverages and confections. Under her leadership, the research and development programs of Libby, Beech-Nut, Carnation, and Nestlé were consolidated into one coordinated function for Nestlé in North America. At PTC New Milford, Dr. Wedral was responsible for the development of innovative new Foodservice Systems and technologies to provide services and solutions for Nestlé's global foodservice customers and operators; one of the food industry's fastest growing markets.
Dr. Wedral received her B.S. (with honors) in Biochemistry from Purdue University and her M.S. and Ph.D. in Microbiology and Food Chemistry from Cornell University. She holds over 39 patents in food science, chemistry and foodservice systems. She has served as Chairman of the Industrial Advisory Board of Columbia University's St. Luke's Roosevelt Hospital Center for Research and Clinical Nutrition and has been on numerous other university advisory boards including Cornell, Purdue, Rutgers, Teikyo Post University and Penn State. She has also received honorary degrees from University of Guadalajara, University Iberoamericana, Purdue University and Teikyo Post University.
Honors and Credentials
- Fellow of the Institute of Food Technologists (IFT)
- "Women of the Year" by the Women in Food, Flavor and Fragrances in Commerce
- Harold H. Macy Food Science and Technology Award from IFT
- The Endre Enderson Award for Food Science Leadership
- State of Connecticut's "Industrial Innovation" Woman of the Year
- Outstanding Food Science Award of Purdue University
Women’s Global Health Institute
Discovery Park and College of Health and Human Sciences
Hall for Discovery and Learning Research, Room 395
207 South Martin Jischke Drive
West Lafayette, IN 47907-1971